Charlyne Julao, DO
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: 057190 · 058496 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Julao’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
State licence records
1 licence
- Florida OS13728Osteopathic Physician · since 2015 · expires 2018-03-31Null And VoidNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
1 placement
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Dermatology
- Internal Medicine
Education
- Touro University · DO2008–2014Medical school
- City College of San Francisco · No Degree2007–2007
- San Francisco State University · No Degree2006–2006
- University of California, Berkeley · Bachelor Degree2002–2004
- Skyline College · No Degree1999–2002
- College of San Mateo · No Degree1998–2001
- Tulane University of Louisiana · MD1966–1970Medical school
Residency and fellowship
- Westchester General Hospital Family Practice Residency, Family PracticeMIAMI, FL · 2014–2016
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$55,044
Medicare paid this office $55,044 for 199 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 132 | $19,866 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 68 | $10,931 | $161 |
| Long return visit (40+ min) | 43 | $7,916 | $141 |
| Short return visit (20+ min) | 35 | $2,972 | $74 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 124 | $2,903 | $14 |
See all 9 services
| Return visit (30+ min) | 132 | $19,866 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 68 | $10,931 | $161 |
| Long return visit (40+ min) | 43 | $7,916 | $141 |
| Short return visit (20+ min) | 35 | $2,972 | $74 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 124 | $2,903 | $14 |
| New patient visit (45+ min) | 18 | $1,912 | $106 |
| Influenza vaccine split virus, preservative free | 17 | $1,371 | $81 |
| Administration of influenza virus vaccine | 20 | $820 | $39 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 18 | $422 | $22 |
Who their Medicare patients are
199 Original Medicare patients in 2024. Average age 77 · Women 70% · Also on Medicaid 16% · Health risk score 1.04. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 66% · Diabetes 27% · Coronary heart disease 20% · Cancer 18% · Atrial fibrillation 18% · Chronic kidney disease 15% · Depression 15% · Heart failure 14% · COPD 10% · Dementia 9% · Stroke 8%.
The office billed $223,842, Medicare allowed $75,870 and paid $55,044; for 712 services of 27 kinds; $3,777 of it was for drugs given in the office and $51,267 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 199 | 712 | 77 | 1.04 | $223,842 | $55,044 |
| 2023 | 201 | 558 | 76 | 1.02 | $235,330 | $60,045 |
| 2022 | 185 | 482 | 78 | 1.04 | $187,412 | $47,098 |
| 2021 | 176 | 510 | 76 | 1.11 | $176,150 | $50,792 |
| 2020 | 128 | 392 | 79 | 1.26 | $98,801 | $30,037 |
| 2019 | 193 | 807 | 79 | 1.22 | $232,859 | $62,778 |
| 2018 | 58 | 101 | 76 | 0.96 | $27,960 | $7,537 |
| 2016 | 13 | 24 | 60 | 1.08 | $4,110 | $1,498 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 112 | $18,856 | $104 |
| Long return visit (40+ min) | 56 | $11,796 | $166 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $9,545 | $159 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 26 | $7,336 | $282 |
| New patient visit (45+ min) | 29 | $3,582 | $124 |
| Short return visit (20+ min) | 39 | $2,880 | $63 |
| Administration of influenza virus vaccine | 27 | $1,018 | $38 |
| Administration of pneumococcal vaccine | 26 | $980 | $38 |
| Influenza vaccine split virus, preservative free | 11 | $781 | $71 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 16 | $350 | $22 |
2022: 10 services
| Return visit (30+ min) | 113 | $19,035 | $105 |
| Short return visit (20+ min) | 58 | $5,839 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $5,654 | $162 |
| Long return visit (40+ min) | 18 | $2,977 | $165 |
| Telephone medical discussion with physician, 21-30 minutes | 26 | $2,525 | $87 |
| New patient visit (45+ min) | 12 | $1,768 | $147 |
| New patient visit (30+ min) | 17 | $1,512 | $89 |
| Influenza vaccine split virus, preservative free | 16 | $1,097 | $69 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $875 | $67 |
| Administration of influenza virus vaccine | 22 | $834 | $38 |
2021: 10 services
| Return visit (30+ min) | 92 | $16,395 | $109 |
| Telephone medical discussion with physician, 21-30 minutes | 48 | $7,125 | $111 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $4,714 | $163 |
| Short return visit (20+ min) | 44 | $3,874 | $79 |
| New patient visit (45+ min) | 27 | $3,856 | $143 |
| Long return visit (40+ min) | 18 | $3,447 | $150 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $2,528 | $55 |
| Influenza vaccine split virus, preservative free | 13 | $840 | $65 |
| New patient visit (30+ min) | 11 | $761 | $69 |
| Administration of influenza virus vaccine | 16 | $347 | $22 |
2020: 6 services
| Telephone medical discussion with physician, 21-30 minutes | 50 | $8,771 | $101 |
| Return visit (30+ min) | 64 | $6,816 | $73 |
| Telephone medical discussion with physician, 11-20 minutes | 45 | $4,000 | $62 |
| Long return visit (40+ min) | 27 | $3,342 | $108 |
| Short return visit (20+ min) | 21 | $1,208 | $53 |
| Administration of influenza virus vaccine | 13 | $271 | $21 |
2019: 12 services
| Return visit (30+ min) | 150 | $30,998 | $90 |
| Pneumococcal vaccine, 13-valent | 39 | $8,090 | $207 |
| Short return visit (20+ min) | 70 | $7,358 | $65 |
| New patient visit (30+ min) | 26 | $2,381 | $92 |
| Long return visit (40+ min) | 13 | $2,186 | $137 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,947 | $139 |
| Influenza vaccine split virus, preservative free | 33 | $1,856 | $55 |
| New patient visit (45+ min) | 14 | $1,550 | $111 |
| Pneumococcal vaccine, 23-valent | 13 | $1,417 | $109 |
| Administration of pneumococcal vaccine | 52 | $1,067 | $21 |
| Administration of influenza virus vaccine | 39 | $841 | $21 |
| Urinalysis, manual test | 17 | $78 | $3 |
2018: 2 services
| Short return visit (20+ min) | 29 | $2,359 | $66 |
| Return visit (30+ min) | 18 | $1,989 | $83 |
Medicaid work
$0 in 2019
Medicaid paid $0 for 43 billed services this clinician did in 2019, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 43 | $0 |
| 2019 | 43 | 1 | 14 | $0 |
Drugs they prescribed that Part D paid
$261,388
Pharmacies billed $261,388 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,630 generic and fewer than 11 brand-name prescriptions · $261,388 in drug cost · 31 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 61 | $83,780 | $1,373 |
| Eliquis | 22 | $34,969 | $1,589 |
| Ozempic | 19 | $28,891 | $1,521 |
| Spiriva Respimat | 11 | $5,599 | $509 |
| Atorvastatin | 291 | $3,366 | $12 |
See all 56 drugs
| Jardiance | 61 | $83,780 | $1,373 |
| Eliquis | 22 | $34,969 | $1,589 |
| Ozempic | 19 | $28,891 | $1,521 |
| Spiriva Respimat | 11 | $5,599 | $509 |
| Atorvastatin | 291 | $3,366 | $12 |
| Fluticasone Propionate Hfa | 13 | $2,958 | $228 |
| Duloxetine | 40 | $2,848 | $71 |
| Budesonide-Formoterol | 11 | $1,958 | $178 |
| Levothyroxine | 148 | $1,830 | $12 |
| Losartan | 200 | $1,783 | $9 |
| Metformin | 166 | $1,503 | $9 |
| Ventolin Hfa | 25 | $1,271 | $51 |
| Carbamazepine Er | 11 | $1,259 | $114 |
| Rosuvastatin | 112 | $1,206 | $11 |
| Gabapentin | 52 | $968 | $19 |
| Amlodipine Besylate | 185 | $938 | $5 |
| Albuterol Sulfate Hfa | 51 | $831 | $16 |
| Metoprolol | 66 | $793 | $12 |
| Lisinopril | 93 | $705 | $8 |
| Pantoprazole | 29 | $589 | $20 |
| Trazodone | 57 | $532 | $9 |
| Allopurinol | 42 | $481 | $11 |
| Simvastatin | 61 | $452 | $7 |
| Tamsulosin | 32 | $433 | $14 |
| Fluticasone Propionate | 38 | $425 | $11 |
| Alendronate | 42 | $424 | $10 |
| Hydroxyzine | 28 | $382 | $14 |
| Furosemide | 55 | $305 | $6 |
| Omeprazole | 28 | $305 | $11 |
| Paroxetine | 16 | $300 | $19 |
| Montelukast | 13 | $273 | $21 |
| Mirtazapine | 12 | $268 | $22 |
| Escitalopram | 20 | $253 | $13 |
| Finasteride | 13 | $252 | $19 |
| Pravastatin | 15 | $245 | $16 |
| Diclofenac | 20 | $243 | $12 |
| Lisinopril-Hydrochlorothiazide | 14 | $210 | $15 |
| Famotidine | 17 | $204 | $12 |
| Benazepril | 31 | $200 | $6 |
| Hydrochlorothiazide | 53 | $194 | $4 |
| Gemfibrozil | 11 | $161 | $15 |
| Glipizide Er | 20 | $156 | $8 |
| Ezetimibe | 11 | $155 | $14 |
| Metoprolol | 19 | $155 | $8 |
| Sertraline | 33 | $152 | $5 |
| Clopidogrel | 14 | $149 | $11 |
| Fluoxetine | 21 | $131 | $6 |
| Zolpidem | 15 | $124 | $8 |
| Atenolol | 15 | $110 | $7 |
| Triamcinolone Acetonide | 23 | $107 | $5 |
| Metformin Hcl Er | 14 | $106 | $8 |
| Losartan-Hydrochlorothiazide | 24 | $95 | $4 |
| Cyclobenzaprine | 12 | $86 | $7 |
| Carvedilol | 17 | $76 | $4 |
| Meloxicam | 22 | $47 | $2 |
| Paxlovid | 19 | $0 | $0 |
Year by year
| 2024 | 2,981 | 313 | None | None | $261,388 |
| 2023 | 2,828 | 293 | None | None | $293,035 |
| 2022 | 2,361 | 255 | None | 11% | $177,015 |
| 2021 | 1,982 | 227 | None | 13% | $157,928 |
| 2020 | 2,152 | 215 | None | 12% | $122,819 |
| 2019 | 1,975 | 233 | 1% (23) | 16% | $117,009 |
| 2018 | 177 | 54 | None | None | $9,657 |
| 2017 | 22 | 19 | None | None | $1,020 |
| 2016 | 38 | 26 | None | None | $420 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 57 drugs
| Jardiance | 46 | $71,530 | $1,555 |
| Ozempic | 23 | $29,587 | $1,286 |
| Eliquis | 16 | $25,882 | $1,618 |
| Breo Ellipta | 12 | $9,138 | $762 |
| Spiriva Respimat | 14 | $7,906 | $565 |
| Atorvastatin | 241 | $4,219 | $18 |
| Losartan | 183 | $3,404 | $19 |
| Rosuvastatin | 85 | $2,840 | $33 |
| Amlodipine Besylate | 179 | $2,646 | $15 |
| Levothyroxine | 157 | $2,525 | $16 |
| Metformin | 184 | $2,071 | $11 |
| Metoprolol | 59 | $1,749 | $30 |
| Lisinopril | 88 | $1,362 | $15 |
| Fluticasone Propionate | 49 | $1,241 | $25 |
| Diclofenac | 39 | $1,204 | $31 |
| Gabapentin | 32 | $1,136 | $35 |
| Valsartan | 13 | $1,123 | $86 |
| Duloxetine | 39 | $1,079 | $28 |
| Ventolin Hfa | 17 | $993 | $58 |
| Alendronate | 45 | $990 | $22 |
| Potassium Chloride | 25 | $978 | $39 |
| Allopurinol | 37 | $940 | $25 |
| Albuterol Sulfate Hfa | 32 | $869 | $27 |
| Benazepril | 24 | $788 | $33 |
| Hydroxyzine | 32 | $754 | $24 |
| Omeprazole | 29 | $735 | $25 |
| Escitalopram | 26 | $699 | $27 |
| Tamsulosin | 35 | $644 | $18 |
| Trazodone | 43 | $596 | $14 |
| Pravastatin | 17 | $560 | $33 |
| Azelastine | 13 | $553 | $43 |
| Simvastatin | 67 | $537 | $8 |
| Venlafaxine Hcl Er | 15 | $532 | $35 |
| Sertraline | 28 | $493 | $18 |
| Mirtazapine | 12 | $486 | $41 |
| Pantoprazole | 29 | $404 | $14 |
| Losartan-Hydrochlorothiazide | 22 | $403 | $18 |
| Furosemide | 58 | $371 | $6 |
| Finasteride | 14 | $366 | $26 |
| Clopidogrel | 18 | $354 | $20 |
| Lisinopril-Hydrochlorothiazide | 20 | $336 | $17 |
| Famotidine | 14 | $311 | $22 |
| Hydrochlorothiazide | 51 | $240 | $5 |
| Carvedilol | 18 | $235 | $13 |
| Glipizide Er | 13 | $200 | $15 |
| Nitrofurantoin Mono-Macro | 12 | $199 | $17 |
| Meclizine | 11 | $193 | $18 |
| Atenolol | 22 | $167 | $8 |
| Citalopram Hbr | 15 | $143 | $10 |
| Montelukast | 11 | $139 | $13 |
| Fluoxetine | 11 | $135 | $12 |
| Triamcinolone Acetonide | 20 | $130 | $6 |
| Glimepiride | 11 | $129 | $12 |
| Metoprolol | 16 | $115 | $7 |
| Cyclobenzaprine | 17 | $66 | $4 |
| Metformin Hcl Er | 12 | $61 | $5 |
| Meloxicam | 12 | $44 | $4 |
2022: 44 drugs
| Jardiance | 39 | $48,979 | $1,256 |
| Latuda | 11 | $16,080 | $1,462 |
| Eliquis | 11 | $14,085 | $1,280 |
| Advair Hfa | 13 | $6,974 | $536 |
| Atorvastatin | 211 | $2,821 | $13 |
| Lantus Solostar | 11 | $2,188 | $199 |
| Levothyroxine | 99 | $2,186 | $22 |
| Rosuvastatin | 66 | $1,758 | $27 |
| Metformin | 177 | $1,498 | $8 |
| Losartan | 118 | $1,387 | $12 |
| Amlodipine Besylate | 142 | $1,333 | $9 |
| Duloxetine | 26 | $1,078 | $41 |
| Metoprolol | 52 | $1,070 | $21 |
| Pantoprazole | 33 | $998 | $30 |
| Fluticasone Propionate | 37 | $916 | $25 |
| Albuterol Sulfate Hfa | 24 | $898 | $37 |
| Gabapentin | 26 | $771 | $30 |
| Alendronate | 43 | $770 | $18 |
| Diclofenac | 28 | $708 | $25 |
| Simvastatin | 72 | $580 | $8 |
| Allopurinol | 24 | $540 | $23 |
| Lisinopril | 87 | $538 | $6 |
| Losartan-Hydrochlorothiazide | 14 | $487 | $35 |
| Trazodone | 47 | $471 | $10 |
| Potassium Chloride | 22 | $451 | $21 |
| Sertraline | 21 | $389 | $19 |
| Escitalopram | 17 | $367 | $22 |
| Finasteride | 14 | $367 | $26 |
| Benazepril | 20 | $326 | $16 |
| Tamsulosin | 22 | $325 | $15 |
| Hydrochlorothiazide | 54 | $296 | $5 |
| Omeprazole | 27 | $294 | $11 |
| Euthyrox | 12 | $287 | $24 |
| Furosemide | 51 | $286 | $6 |
| Clopidogrel | 17 | $269 | $16 |
| Carvedilol | 14 | $262 | $19 |
| Lisinopril-Hydrochlorothiazide | 21 | $244 | $12 |
| Atenolol | 20 | $220 | $11 |
| Triamterene-Hydrochlorothiazid | 11 | $196 | $18 |
| Triamcinolone Acetonide | 18 | $132 | $7 |
| Citalopram Hbr | 12 | $108 | $9 |
| Cyclobenzaprine | 21 | $86 | $4 |
| Meloxicam | 31 | $80 | $3 |
| Naproxen | 12 | $32 | $3 |
2021: 37 drugs
| Jardiance | 28 | $42,151 | $1,505 |
| Eliquis | 12 | $14,870 | $1,239 |
| Lantus Solostar | 16 | $3,247 | $203 |
| Levothyroxine | 103 | $2,473 | $24 |
| Atorvastatin | 149 | $2,119 | $14 |
| Amlodipine Besylate | 132 | $1,320 | $10 |
| Losartan | 95 | $1,255 | $13 |
| Rosuvastatin | 37 | $1,168 | $32 |
| Metformin | 151 | $1,028 | $7 |
| Synthroid | 14 | $872 | $62 |
| Memantine | 15 | $781 | $52 |
| Gabapentin | 28 | $755 | $27 |
| Metoprolol | 33 | $712 | $22 |
| Finasteride | 16 | $702 | $44 |
| Pantoprazole | 31 | $682 | $22 |
| Lisinopril | 83 | $661 | $8 |
| Potassium Chloride | 26 | $579 | $22 |
| Albuterol Sulfate Hfa | 14 | $568 | $41 |
| Simvastatin | 70 | $554 | $8 |
| Diclofenac | 24 | $468 | $20 |
| Trazodone | 36 | $454 | $13 |
| Sertraline | 20 | $450 | $23 |
| Tamsulosin | 23 | $438 | $19 |
| Allopurinol | 16 | $426 | $27 |
| Nitrofurantoin Mono-Macro | 24 | $390 | $16 |
| Fluticasone Propionate | 30 | $364 | $12 |
| Valacyclovir | 13 | $333 | $26 |
| Omeprazole | 20 | $274 | $14 |
| Atenolol | 26 | $250 | $10 |
| Alendronate | 16 | $242 | $15 |
| Furosemide | 39 | $203 | $5 |
| Hydrochlorothiazide | 32 | $200 | $6 |
| Lisinopril-Hydrochlorothiazide | 21 | $196 | $9 |
| Clopidogrel | 11 | $130 | $12 |
| Citalopram Hbr | 11 | $105 | $10 |
| Cyclobenzaprine | 15 | $78 | $5 |
| Glimepiride | 12 | $74 | $6 |
2020: 47 drugs
| Januvia | 15 | $15,104 | $1,007 |
| Trulicity | 11 | $8,597 | $782 |
| Lantus Solostar | 20 | $4,530 | $227 |
| Levothyroxine | 101 | $2,732 | $27 |
| Atorvastatin | 165 | $2,505 | $15 |
| Losartan | 96 | $1,292 | $13 |
| Amlodipine Besylate | 120 | $1,207 | $10 |
| Metformin | 127 | $980 | $8 |
| Lisinopril | 97 | $972 | $10 |
| Potassium Chloride | 28 | $880 | $31 |
| Gabapentin | 49 | $859 | $18 |
| Memantine | 16 | $856 | $53 |
| Diclofenac | 36 | $839 | $23 |
| Metoprolol | 30 | $830 | $28 |
| Pantoprazole | 35 | $765 | $22 |
| Valacyclovir | 18 | $733 | $41 |
| Rosuvastatin | 20 | $714 | $36 |
| Tamsulosin | 26 | $571 | $22 |
| Furosemide | 84 | $530 | $6 |
| Famotidine | 22 | $504 | $23 |
| Omeprazole | 28 | $489 | $17 |
| Fluticasone Propionate | 45 | $468 | $10 |
| Finasteride | 14 | $455 | $32 |
| Duloxetine | 12 | $427 | $36 |
| Albuterol Sulfate Hfa | 11 | $420 | $38 |
| Diltiazem 24hr Er (Cd) | 13 | $410 | $32 |
| Simvastatin | 54 | $373 | $7 |
| Clopidogrel | 24 | $349 | $15 |
| Atenolol | 37 | $337 | $9 |
| Glimepiride | 21 | $324 | $15 |
| Hydralazine | 11 | $310 | $28 |
| Allopurinol | 15 | $304 | $20 |
| Donepezil | 21 | $302 | $14 |
| Alendronate | 24 | $245 | $10 |
| Sertraline | 17 | $202 | $12 |
| Hydrochlorothiazide | 41 | $200 | $5 |
| Nitrofurantoin Mono-Macro | 11 | $191 | $17 |
| Carvedilol | 15 | $181 | $12 |
| Trazodone | 23 | $159 | $7 |
| Isosorbide Mononitrate Er | 16 | $158 | $10 |
| Glipizide | 30 | $146 | $5 |
| Lisinopril-Hydrochlorothiazide | 16 | $118 | $7 |
| Citalopram Hbr | 12 | $106 | $9 |
| Ibuprofen | 12 | $105 | $9 |
| Metoprolol | 11 | $62 | $6 |
| Cephalexin | 11 | $53 | $5 |
| Naproxen | 13 | $44 | $3 |
2019: 46 drugs
| Levemir Flextouch | 16 | $6,300 | $394 |
| Lantus Solostar | 19 | $4,411 | $232 |
| Levothyroxine | 89 | $2,259 | $25 |
| Atorvastatin | 114 | $1,975 | $17 |
| Shingrix | 11 | $1,827 | $166 |
| Potassium Chloride | 25 | $1,199 | $48 |
| Gabapentin | 52 | $1,078 | $21 |
| Diclofenac | 33 | $1,038 | $31 |
| Amlodipine Besylate | 97 | $965 | $10 |
| Losartan | 85 | $940 | $11 |
| Metformin | 95 | $875 | $9 |
| Lisinopril | 76 | $846 | $11 |
| Valacyclovir | 19 | $750 | $39 |
| Memantine | 14 | $743 | $53 |
| Furosemide | 86 | $639 | $7 |
| Omeprazole | 29 | $610 | $21 |
| Pantoprazole | 46 | $572 | $12 |
| Fluticasone Propionate | 44 | $535 | $12 |
| Metoprolol | 25 | $481 | $19 |
| Tamsulosin | 21 | $417 | $20 |
| Finasteride | 16 | $397 | $25 |
| Carvedilol | 25 | $352 | $14 |
| Hydrochlorothiazide | 39 | $335 | $9 |
| Atenolol | 28 | $310 | $11 |
| Simvastatin | 34 | $304 | $9 |
| Hydralazine | 22 | $289 | $13 |
| Trazodone | 26 | $282 | $11 |
| Donepezil | 14 | $275 | $20 |
| Allopurinol | 11 | $264 | $24 |
| Ranitidine | 21 | $263 | $13 |
| Lovastatin | 12 | $252 | $21 |
| Sertraline | 30 | $240 | $8 |
| Isosorbide Mononitrate Er | 11 | $218 | $20 |
| Glimepiride | 15 | $204 | $14 |
| Alendronate | 18 | $182 | $10 |
| Glipizide | 24 | $180 | $7 |
| Nitrofurantoin Mono-Macro | 12 | $176 | $15 |
| Zolpidem | 12 | $113 | $9 |
| Warfarin | 12 | $91 | $8 |
| Naproxen | 22 | $90 | $4 |
| Triamcinolone Acetonide | 14 | $80 | $6 |
| Metoprolol | 16 | $78 | $5 |
| Citalopram Hbr | 11 | $76 | $7 |
| Tramadol | 13 | $70 | $5 |
| Meloxicam | 19 | $53 | $3 |
| Clopidogrel | 13 | $51 | $4 |
2018: 1 drug
| Gabapentin | 11 | $152 | $14 |
Money from drug and device companies
$552 in 2025
| 2025 | 7 | 19 | None | $552 |
| 2024 | 2 | 3 | None | $66 |
| 2023 | 3 | 4 | None | $201 |
| 2020 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | The Cologuard Plus Collection Kit | $274 | 7 payments
|
| Novo Nordisk | Wegovy | $122 | 5 payments
|
| Pfizer | Paxlovid | $53 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $27 | 1 payment
|
| Dynavax Technologies | Heplisav-B | $27 | 1 payment
|
| Amgen | Evenity | $26 | 1 payment
|
See all 19 published payments
| Pfizer | Meals · 2025-12-09 | Eliquis | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-25 | Jardiance | $27 |
| Exact Sciences | Meals · 2025-11-19 | The Cologuard Plus Collection Kit | $22 |
| Pfizer | Meals · 2025-11-18 | Prevnar 20 | $16 |
| Dexcom | Meals · 2025-10-20 | Dexcom G6 Transmitter | $24 |
| Novo Nordisk | Meals · 2025-10-01 | Wegovy | $34 |
| Novo Nordisk | Meals · 2025-09-23 | None | $21 |
| Exact Sciences | Meals · 2025-09-22 | The Cologuard Plus Collection Kit | $20 |
| Pfizer | Meals · 2025-09-03 | Paxlovid | $19 |
| Exact Sciences | Meals · 2025-07-22 | The Cologuard Plus Collection Kit | $24 |
| Novo Nordisk | Meals · 2025-06-26 | None | $22 |
| Exact Sciences | Meals · 2025-06-11 | The Cologuard Plus Collection Kit | $125 |
| Novo Nordisk | Meals · 2025-06-10 | Wegovy | $26 |
| Dynavax Technologies | Meals · 2025-06-04 | Heplisav-B | $27 |
| Exact Sciences | Meals · 2025-05-22 | The Cologuard Plus Collection Kit | $29 |
| Novo Nordisk | Meals · 2025-05-15 | Rybelsus | $19 |
| Amgen | Meals · 2025-05-13 | Evenity | $26 |
| Exact Sciences | Meals · 2025-03-18 | Cologuard Collection Kit | $26 |
| Exact Sciences | Meals · 2025-01-21 | The Cologuard Plus Collection Kit | $28 |
See earlier years (2024, 2023, 2020)
2024: $66
| Exact Sciences | Cologuard Collection Kit | $48 | 2 payments
|
| Dynavax Technologies | Heplisav-B | $17 | 1 payment
|
2023: $201
| GlaxoSmithKline | Arexvy | $122 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $45 | 2 payments
|
| Dynavax Technologies | Heplisav-B | $34 | 1 payment
|
2020: $14
| GlaxoSmithKline | Shingrix | $14 | 1 payment
|
Professional record
- NPI
- 1457710527
- Licence
- CA 20A14900, FL OS13728Florida OS13728: Null And Void
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 828 S Winchester Blvd, San Jose, CA, 95128
- NPI first listed
- 2016-02-18
- NPI last updated
- 2020-11-30
- NPI record certified
- 2020-11-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2495 Hospital Dr Ste 460, Mountain View, CA, 94040